BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 15327425)

  • 41. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
    ter Wee PM; Beelen RH; van den Born J
    Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
    Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
    Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
    Opatrna S; Popperlova A; Kalousová M; Zima T
    Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of bicarbonate dialysis solution on peritoneal transport in rats.
    Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ
    Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
    Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
    Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
    Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
    Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
    Ha H; Cha MK; Choi HN; Lee HB
    Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study.
    Rodríguez-Carmona A; Pérez-Fontán M; Guitián A; Peteiro J; García-Falcón T; López-Muñiz A; García-Buela J; Cordido F
    Nephrol Dial Transplant; 2012 Jan; 27(1):369-74. PubMed ID: 21562143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
    Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
    Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.
    de Graaff M; Zegwaard AH; Zweers MM; Vlijm A; de Waart DR; Vandemaele F; Struijk DG; Krediet RT
    Perit Dial Int; 2010; 30(2):192-200. PubMed ID: 20124192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid.
    Grossin N; Wautier MP; Wautier JL; Gane P; Taamma R; Boulanger E
    Perit Dial Int; 2006; 26(6):664-70. PubMed ID: 17047233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
    Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
    Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
    Eich G; Bartosova M; Tischer C; Wlodkowski TT; Schaefer B; Pichl S; Kraewer N; Ranchin B; Vondrak K; Liebau MC; Hackert T; Schmitt CP
    PLoS One; 2017; 12(12):e0189903. PubMed ID: 29253861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
    Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
    Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
    Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
    Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.